Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
October 7, 2019
Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial
Advaxis, Inc. (ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced updated median overall survival data from ...
October 7, 2019
Motus GI Announces First Commercial Placements of Pure-Vu® System as part of U.S. Market Launch
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Motus GI Holdings, Inc., (MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and enhancing the ...
October 7, 2019
TRACON Pharmaceuticals Announces that Scientific Advisor William Kaelin, Jr., M.D. was Awarded the 2019 Nobel Prize in Physiology or Medicine
SAN DIEGO, Oct. 07, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), announced today that William Kaelin Jr., M.D., a member of TRACON’s Scientific Advisory Board ...
October 7, 2019
Cue Biopharma Promotes Dr. Anish Suri to President and CSO
CAMBRIDGE, Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (CUE) a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively ...
October 7, 2019
Strata Skin Sciences Receives Nasdaq Notice of Non-compliance
HORSHAM, Pa., Oct. 07, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic ...
October 3, 2019
Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it will host a Research & Development (R&D) Day to discuss its emerging pipeline of RNAi ...
October 3, 2019
ADMA Biologics Announces Poster Presentation at IDWeek 2019
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 03, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
October 3, 2019
Catalyst Biosciences Provides DalcA Phase 2b Trial Update
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), today provided an update on enrollment in its Phase 2b study ...
October 3, 2019
Albireo Recognizes PFIC Awareness Day and Highlights Urgent Needs of Progressive Familial Intrahepatic Cholestasis Families
BOSTON, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today ...
October 3, 2019
SkinTE Data to be Presented at the 19th Annual Diabetic Foot Global Conference
SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that two abstracts demonstrating the impact ...
October 3, 2019
Tetra Bio-Pharma Provides Regulatory Update for Its CAUMZ(TM) Kit
OTTAWA, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., (TBP.V) (TBPMF), a leader in drug discovery and development for cannabinoid-based therapeutics, today announced the ...
October 3, 2019
Cidara Therapeutics to Present New Clinical and Preclinical Data at Two Upcoming Medical Conferences
SAN DIEGO, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it will ...
October 2, 2019
Celyad Announces October and November 2019 Investor Conference Schedule
MONT-SAINT-GUIBERT, Belgium, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
October 2, 2019
Celyad to Present Update on mCRC Clinical Program at the 2019 SITC Annual Meeting
MONT-SAINT-GUIBERT, Belgium, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
October 2, 2019
Compugen to Present Data from Ongoing COM701 Phase 1 Clinical Trial at SITC 2019
HOLON, Israel, Oct. 2, 2019 /PRNewswire/ -- October 2, 2019 – Compugen Ltd. (CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, today announced ...
October 2, 2019
Vericel and MediWound Announce Initiation of U.S. NexoBrid Expanded Access Treatment Protocol
CAMBRIDGE, Mass. and YAVNE, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (VCEL) and MediWound Ltd. (MDWD) today announced initiation of the NexoBrid® expanded ...
October 2, 2019
Soleno Therapeutics Announces Positive Outcome from Second Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome
REDWOOD CITY, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
October 2, 2019
DURECT Announces FDA Advisory Committee Meeting to Review POSIMIR® for the Treatment of Post-Surgical Pain
CUPERTINO, Calif., Oct. 2, 2019 /PRNewswire/ -- DURECT Corporation (DRRX) announced today that the U.S. Food and Drug Administration (FDA) has notified the Company that its ...
October 2, 2019
Cue Biopharma to Present Corporate Overview and Update on Clinical Development Progress for CUE-101 at the Cantor 2019 Global Healthcare Conference
CAMBRIDGE, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively ...
October 2, 2019
CytoSorbents Announces Positive Surgical Outcomes From CytoSorb Removal Of Antithrombotics In Emergency Cardiothoracic Surgery
MONMOUTH JUNCTION, N.J., Oct. 2, 2019 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a leader using its CytoSorb® blood purification technology to treat life-threatening medical and surgical conditions around the ...
Page 4 of 169